The Correlation of Tissue p53 Protein Overexpression and p53 Antigen in Serum of Patients with Bladder Cancer

References

• Levine A.J. Momand J. Finlay C.A. 1991 The p53 tumor suppressor gene Nature 351 453 456
   Google Scholar
• Hollstein M. Sidransky D. Vogelstein B. Harris C.C. 1991 p53 Mutations in human cancers Science 253 49 53
   Google Scholar
• Burksrtm C. Das 1994 Tumor suppressor protein p53 Deutsheus Arzteblatt. 91 679 684
   Google Scholar
• Soussl T. 1994 The humoral immune response to the tumor suppressor gene-product p53 in human cancer: implications for diagnosis and therapies Immunol. Today 17 8 354 356
   Google Scholar
• Fountanini G. Fiore L. Bigini D. Vignati S. Calvo S. Mussi A. Lucchi M. Angeletti C.A. Merlo G.R Basolo F. 1994 Levels of p53 antigen in serum of non-small cell lung cancer patients correlate with positive p53 immunohistochemistry on tumor sections, tumor necrosis and nodal involvement Int. J. Oncol. 5 553 558
   Google Scholar
• Luo J.C. Neugut A.I. Garbowski G. Forde K.A. Treat M. Smith S. Carney W.P Brandt-Rauf P.W. 1995 Levels of p53 antigen in the plasma of patients with adenomas and carcinomas of the colon Cancer Lett. 91 235 240
   Google Scholar
• Suwa H. Ohshio G. Okada N. Wang Z. Fukurnoto M. Imamura T. Imamura M. 1997 Clinical significance of serum p53 antigen in patients with pancreatic carcinomas Gut 40 647 653
   Google Scholar
• Finlay C.A. Hinds P.W. Tan T.H. 1988 Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life Mol. Cell. Biol. 8 531 539
   Google Scholar
• Tatsuo M. Nobuyuki T. Takatoshi K. Akinori N. Hitoshi I. Kazumi S. Akihiko T. 2000 Serum anti-p53 antibodies and p53 protein status in the sera and tumors from bladder cancer patients Eur. Urol. 37 79 84
   Google Scholar
• Barbati A. Mariani L. Porpora M.G. Anceschi M. Collini P. Lauro V. Cosmi E.V. 2000 Serum evaluation of P53 protein in patients with gynaecological cancer Anticancer Res. 20 1033 1035
   Google Scholar
• Segawa Y. Takigawa N. Maeda Y. Mandai K. Takata I. Fujimoto N. Jinno K. 1997 Measurement of serum p53 protein in patients with small cell lung cancer and results of its clinicopathological evaluation Lung Cancer 16 229 238
   Google Scholar
• Lipponen P.K. 1993 Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value Int. J. Cancer 53 365 370
   Google Scholar
• Esrig D. Elmajian D. Groshen S. Freeman J.A. Stein J.P. Chen S.C. Nichols P.W. Skinner D.G. Jones P.A. Cote R.J. 1994 Accumulation of nuclear p53 and tumor progression in bladder cancer N. Engl. J. Med. 331 1259 1264
   Google Scholar
• Kay E.W. Barry Walsh C.J. Whelan D. O'Grady A. Leader M.B. 1996 Interobserver variation of p53 immunohistochemistry—an assessment of a practical problem and comparison with other studies Br. J. Biomed. Sci. 53 101 107
   Google Scholar
• Tsai Y.C. Olumi A.F. Nichols P.W. Skinner D.G. Cain D.R. Bender L.I. Jones P.A. 1990 Allelic loss of chromosome 17p distinguishes high grade from low-grade transitional cell carcinomas of the bladder Cancer Res. 50 7081
   Google Scholar
• Sidransky D. von Eschenbach A. Tsai Y.C. Jones P. Summerhayes I. Marshall F. Paul M. Green P. Hamilton S.R. Frost P. 1991 Identification of p53 gene mutations in bladder cancers and urine samples Science 252 706 709
   Google Scholar
• Underwood M.A. Reeves J. Smith G. Gardiner D.S. Scott R. Bartlett J. Cooke T.G. 1996 Overexpression of p53 protein and its significance for recurrent progressive bladder tumors Br. J. Urol. 77 659 666
   Google Scholar